CAN
ALXN

Cetera Advisor Networks’s Alexion Pharmaceuticals ALXN Stock Holding History

Cetera Advisor Networks’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-7,761
Closed -$1.43M – 2087
2021
Q2 		$1.43M Buy
7,761
+5,011
+182% +$860K 0.02% 660
2021
Q1 		$421K Buy
2,750
+34
+1% +$5.26K 0.01% 966
2020
Q4 		$424K Sell
2,716
-1,075
-28% -$138K 0.01% 860
2020
Q3 		$434K Buy
3,791
+2,570
+210% +$277K 0.01% 767
2020
Q2 		$137K Buy
+1,221
New +$130K ﹤0.01% 1329
2019
Q2 		– Sell
-2,716
Closed -$370K – 1250
2019
Q1 		$370K Buy
2,716
+391
+17% +$48.6K 0.01% 785
2018
Q4 		$229K Sell
2,325
-1,244
-35% -$147K 0.01% 883
2018
Q3 		$501K Buy
3,569
+475
+15% +$59.6K 0.02% 633
2018
Q2 		$383K Buy
3,094
+455
+17% +$53.2K 0.02% 557
2018
Q1 		$295K Buy
2,639
+409
+18% +$48.9K 0.01% 671
2017
Q4 		$268K Buy
2,230
+405
+22% +$49.3K 0.01% 786
2017
Q3 		$256K Buy
1,825
+35
+2% +$4.75K 0.01% 744
2017
Q2 		$218K Sell
1,790
-32
-2% -$3.72K 0.01% 814
2017
Q1 		$221K Hold
1,822
– – 0.01% 802
2016
Q4 		$224K Sell
1,822
-178
-9% -$21.8K 0.01% 756
2016
Q3 		$245K Buy
2,000
+157
+9% +$20.2K 0.01% 852
2016
Q2 		$215K Buy
1,843
+96
+5% +$13.6K 0.01% 743
2016
Q1 		$243K Hold
1,747
– – 0.02% 682
2015
Q4 		$334K Hold
1,747
– – 0.02% 571
2015
Q3 		$272K Sell
1,747
-795
-31% -$145K 0.02% 611
2015
Q2 		$441K Hold
2,542
– – 0.03% 489
2015
Q1 		$441K Sell
2,542
-963
-27% -$174K 0.03% 492
2014
Q4 		$648K Buy
3,505
+1,507
+75% +$279K 0.05% 378
2014
Q3 		$330K Buy
+1,998
New +$328K 0.02% 572
2014
Q2 		– Sell
-1,655
Closed -$251K – 830
2014
Q1 		$251K Sell
1,655
-39
-2% -$6.2K 0.02% 634
2013
Q4 		$225K Buy
+1,694
New +$203K 0.02% 647

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $434M AUM 44.19% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

Cetera Advisor Networks's ALXN Position: Q3 2021 in Review

Cetera Advisor Networks sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 7,761 shares — an estimated $1.43M sold.

Cetera Advisor Networks first reported a position in ALXN in Q4 2013 and held it in 26 quarters. The position peaked at $1.43M in Q2 2021. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Cetera Advisor Networks reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Cetera Advisor Networks sold 7,761 Alexion Pharmaceuticals shares in Q3 2021, an estimated $1.43M.
  • Cetera Advisor Networks first reported a position in Alexion Pharmaceuticals in Q4 2013 and held it in 26 quarters.
  • Cetera Advisor Networks's Alexion Pharmaceuticals position peaked at $1.43M in Q2 2021.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Cetera Advisor Networks's 13F filing for Q3 2021, filed 16 Nov 2021.